Browse by topic
- View All
- Agricultural and Vet Science
- Arts, Culture and Performance
- Built Environment and Design
- Business and Management
- COVID-19 Related
- Digital Technology Supercluster
- Earth Sciences
- Environmental Sciences
- History and Archaeology
- Human Society
- Indigenous Studies
- Information and Computing Science
- International Development
- Language, Communications and Culture
- Law and Legal Studies
- Medical and Health Science
- Philosophy and Religious Studies
- Policy and Political Science
- Research Tools
NIH Updates & Reminders
Applicants must use FORMS-G application packages for due dates on or after January 25, 2022 and must use FORMS-F application packages for due dates on or before January 24, 2022. Applications submitted using the wrong forms for their intended due date may be withdrawn and removed from funding consideration.
Availability of FORMS-G Application Guides
Application guides for FORMS-G application packages will be posted to the How to Apply - Application Guide page no later than October 25, 2021.
Availability of FORMS-G Application Packages
FORMS-G application packages will be posted as follows
- New funding opportunity announcements (FOAs) will be posted with FORMS-G application packages beginning October 25, 2021.
- New FOAs posted before October 25, 2021 with initial due dates on or after January 25, 2022 will be posted without application forms until updated forms are available. Application packages will be added to these FOAs by November 25, 2021.
- All active Parent and IC-issued FOAs with due dates on or after January 25, 2022 will be updated to add FORMS-G application packages between October 25, 2021 and November 25, 2021.
For a transition period, both FORMS-F and FORMS-G application packages will be active simultaneously. Applicants must choose the appropriate application package for their due date when presented with both FORMS-F and FORMS-G application packages on the same FOA (see table below).
|If your intended due date is...||You must use...|
On or before January 24, 2022, including:
|FORMS-F application package|
On or after January 25, 2022, including:
|FORMS-G application packag|
- NIH will require the use of the updated Biographical Sketch and Other Support format pages for submissions on or after January 25, 2022. See more about this here: NOT-OD-21-073, NOT-OD-21-110, and NOT-OD-21-122 .
- Targeting due dates on or after January 25, 2022, all Senior/Key personnel listed on the R&R Senior/Key Person Profile (Expanded) form will be required to have an eRA Commons username (Commons ID). If you require eRA Commons username, please contact email@example.com.
- As part of the federal-wide transition from the DUN and Bradstreet (D&B) Data Universal Numbering System (DUNS) number to the new government-owned Unique Entity Identifier (UEI), applicants will be required to have a UEI to apply for federal grants or cooperative agreements. ORS is working on this and will notify researchers in due time.
- Prohibition on expending NIH grant funds for covered telecommunications equipment or services:
Recipients and subrecipients are prohibited from expending grant funds to:
- Procure or obtain;
- Extend or renew a contract to procure or obtain; or
- Enter into a contract (or extend or renew a contract) to procure or obtain equipment, services, or systems that use covered telecommunications equipment or services as a substantial or essential component of any system, or as critical technology as part of any system.
Section 889 of the NDAA of 2019 defines “covered telecommunications equipment or services” to mean telecommunications and video surveillance equipment or services produced by Huawei Technologies Company, ZTE Corporation, Hytera Communications Corporation, Hangzhou Hikvision Digital Technology Company, or Dahua Technology Company (or any subsidiary or affiliate of such entities). “Covered telecommunications equipment or services” also includes telecommunications or video surveillance equipment or services provided by an entity that the Secretary of Defense, in consultation with the Director of the National Intelligence or the Director of the Federal Bureau of Investigation, reasonably believes to be an entity that is owned or controlled by the government of a covered foreign country.